Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 5.73493 | 81 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 6.12278 | 83 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 6.63813 | 87 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 6.38024 | 84 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 6.17689 | 83 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 5.93948 | 83 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 5.80017 | 82 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 6.13375 | 84 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 6.07842 | 83 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 5.84923 | 81 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 5.63565 | 80 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 5.80815 | 81 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 6.12081 | 83 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 5.77073 | 81 |